nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HTR1B—dura mater—peripheral nervous system neoplasm	0.0351	0.115	CbGeAlD
Amoxapine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0199	0.0648	CbGeAlD
Amoxapine—HTR3A—vagus nerve—peripheral nervous system neoplasm	0.0168	0.0549	CbGeAlD
Amoxapine—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.0151	0.0493	CbGeAlD
Amoxapine—HTR3A—cranial nerve—peripheral nervous system neoplasm	0.0128	0.0418	CbGeAlD
Amoxapine—HTR7—vagus nerve—peripheral nervous system neoplasm	0.0109	0.0355	CbGeAlD
Amoxapine—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.0108	0.0351	CbGeAlD
Amoxapine—HTR6—ganglion—peripheral nervous system neoplasm	0.00904	0.0295	CbGeAlD
Amoxapine—HTR7—cranial nerve—peripheral nervous system neoplasm	0.0083	0.0271	CbGeAlD
Amoxapine—HTR7—pons—peripheral nervous system neoplasm	0.0082	0.0267	CbGeAlD
Amoxapine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00727	0.0237	CbGeAlD
Amoxapine—DRD1—nerve—peripheral nervous system neoplasm	0.00681	0.0222	CbGeAlD
Amoxapine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.0068	0.0222	CbGeAlD
Amoxapine—DRD1—ganglion—peripheral nervous system neoplasm	0.00673	0.0219	CbGeAlD
Amoxapine—HTR3A—nerve—peripheral nervous system neoplasm	0.00658	0.0214	CbGeAlD
Amoxapine—HTR3A—ganglion—peripheral nervous system neoplasm	0.0065	0.0212	CbGeAlD
Amoxapine—SLC6A3—nerve—peripheral nervous system neoplasm	0.00547	0.0178	CbGeAlD
Amoxapine—HTR1B—ganglion—peripheral nervous system neoplasm	0.00545	0.0178	CbGeAlD
Amoxapine—SLC6A3—ganglion—peripheral nervous system neoplasm	0.0054	0.0176	CbGeAlD
Amoxapine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00522	0.017	CbGeAlD
Amoxapine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00518	0.0169	CbGeAlD
Amoxapine—HTR2A—pons—peripheral nervous system neoplasm	0.00512	0.0167	CbGeAlD
Amoxapine—SLC6A4—ganglion—peripheral nervous system neoplasm	0.00495	0.0161	CbGeAlD
Amoxapine—SLC6A2—nerve—peripheral nervous system neoplasm	0.00441	0.0144	CbGeAlD
Amoxapine—HTR1A—ganglion—peripheral nervous system neoplasm	0.0044	0.0143	CbGeAlD
Amoxapine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00436	0.0142	CbGeAlD
Amoxapine—HTR7—nerve—peripheral nervous system neoplasm	0.00426	0.0139	CbGeAlD
Amoxapine—HTR7—ganglion—peripheral nervous system neoplasm	0.0042	0.0137	CbGeAlD
Amoxapine—DRD2—nerve—peripheral nervous system neoplasm	0.00402	0.0131	CbGeAlD
Amoxapine—DRD2—ganglion—peripheral nervous system neoplasm	0.00397	0.013	CbGeAlD
Amoxapine—HTR3A—trigeminal ganglion—peripheral nervous system neoplasm	0.00319	0.0104	CbGeAlD
Amoxapine—DRD1—brainstem—peripheral nervous system neoplasm	0.00292	0.00953	CbGeAlD
Amoxapine—HTR3A—brainstem—peripheral nervous system neoplasm	0.00282	0.0092	CbGeAlD
Amoxapine—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00268	0.00872	CbGeAlD
Amoxapine—HTR2A—nerve—peripheral nervous system neoplasm	0.00265	0.00865	CbGeAlD
Amoxapine—HTR2A—ganglion—peripheral nervous system neoplasm	0.00262	0.00854	CbGeAlD
Amoxapine—HTR1B—brainstem—peripheral nervous system neoplasm	0.00237	0.00772	CbGeAlD
Amoxapine—GABRA1—brainstem—peripheral nervous system neoplasm	0.00237	0.00772	CbGeAlD
Amoxapine—SLC6A3—brainstem—peripheral nervous system neoplasm	0.00235	0.00766	CbGeAlD
Amoxapine—CHRM1—parotid gland—peripheral nervous system neoplasm	0.00229	0.00745	CbGeAlD
Amoxapine—HTR2C—brainstem—peripheral nervous system neoplasm	0.00227	0.0074	CbGeAlD
Amoxapine—SLC6A4—brainstem—peripheral nervous system neoplasm	0.00215	0.00702	CbGeAlD
Amoxapine—HTR1A—brainstem—peripheral nervous system neoplasm	0.00191	0.00623	CbGeAlD
Amoxapine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.0019	0.00618	CbGeAlD
Amoxapine—HTR7—brainstem—peripheral nervous system neoplasm	0.00183	0.00595	CbGeAlD
Amoxapine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.00176	0.00574	CbGeAlD
Amoxapine—DRD2—brainstem—peripheral nervous system neoplasm	0.00173	0.00563	CbGeAlD
Amoxapine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.00154	0.00502	CbGeAlD
Amoxapine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.00151	0.00493	CbGeAlD
Amoxapine—Desloratadine—ABCB1—peripheral nervous system neoplasm	0.00141	0.512	CrCbGaD
Amoxapine—GABRA1—cerebellum—peripheral nervous system neoplasm	0.00117	0.00381	CbGeAlD
Amoxapine—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.00116	0.00378	CbGeAlD
Amoxapine—HTR2A—brainstem—peripheral nervous system neoplasm	0.00114	0.00371	CbGeAlD
Amoxapine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.00104	0.00338	CbGeAlD
Amoxapine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000942	0.00307	CbGeAlD
Amoxapine—HTR7—cerebellum—peripheral nervous system neoplasm	0.000901	0.00294	CbGeAlD
Amoxapine—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000869	0.00283	CbGeAlD
Amoxapine—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000857	0.00175	CcSEcCtD
Amoxapine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000851	0.00278	CbGeAlD
Amoxapine—Oedema—Vincristine—peripheral nervous system neoplasm	0.000851	0.00174	CcSEcCtD
Amoxapine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000843	0.00172	CcSEcCtD
Amoxapine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000842	0.00172	CcSEcCtD
Amoxapine—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000837	0.00171	CcSEcCtD
Amoxapine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000836	0.00171	CcSEcCtD
Amoxapine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000836	0.00171	CcSEcCtD
Amoxapine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000833	0.0017	CcSEcCtD
Amoxapine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000831	0.0017	CcSEcCtD
Amoxapine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000828	0.00169	CcSEcCtD
Amoxapine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000827	0.00169	CcSEcCtD
Amoxapine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000825	0.00169	CcSEcCtD
Amoxapine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000825	0.00169	CcSEcCtD
Amoxapine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000825	0.00169	CcSEcCtD
Amoxapine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000824	0.00169	CcSEcCtD
Amoxapine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000824	0.00169	CcSEcCtD
Amoxapine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000821	0.00168	CcSEcCtD
Amoxapine—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000816	0.00167	CcSEcCtD
Amoxapine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000814	0.00166	CcSEcCtD
Amoxapine—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000813	0.00166	CcSEcCtD
Amoxapine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000811	0.00166	CcSEcCtD
Amoxapine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000804	0.00164	CcSEcCtD
Amoxapine—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000802	0.00164	CcSEcCtD
Amoxapine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000799	0.00163	CcSEcCtD
Amoxapine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000799	0.00163	CcSEcCtD
Amoxapine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000797	0.00163	CcSEcCtD
Amoxapine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000797	0.00163	CcSEcCtD
Amoxapine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000795	0.00163	CcSEcCtD
Amoxapine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000793	0.00162	CcSEcCtD
Amoxapine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000787	0.00161	CcSEcCtD
Amoxapine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000785	0.00161	CcSEcCtD
Amoxapine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000785	0.0016	CcSEcCtD
Amoxapine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000779	0.00159	CcSEcCtD
Amoxapine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000777	0.00159	CcSEcCtD
Amoxapine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000777	0.00159	CcSEcCtD
Amoxapine—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000774	0.00158	CcSEcCtD
Amoxapine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000771	0.00158	CcSEcCtD
Amoxapine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000771	0.00158	CcSEcCtD
Amoxapine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00077	0.00157	CcSEcCtD
Amoxapine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000768	0.00157	CcSEcCtD
Amoxapine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000764	0.00156	CcSEcCtD
Amoxapine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000761	0.00156	CcSEcCtD
Amoxapine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000756	0.00155	CcSEcCtD
Amoxapine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000755	0.00154	CcSEcCtD
Amoxapine—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000755	0.00154	CcSEcCtD
Amoxapine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000753	0.00154	CcSEcCtD
Amoxapine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000753	0.00154	CcSEcCtD
Amoxapine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000752	0.00154	CcSEcCtD
Amoxapine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000747	0.00153	CcSEcCtD
Amoxapine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000742	0.00152	CcSEcCtD
Amoxapine—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000742	0.00152	CcSEcCtD
Amoxapine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000741	0.00151	CcSEcCtD
Amoxapine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000741	0.00151	CcSEcCtD
Amoxapine—Rash—Topotecan—peripheral nervous system neoplasm	0.000741	0.00151	CcSEcCtD
Amoxapine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00074	0.00151	CcSEcCtD
Amoxapine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00074	0.00151	CcSEcCtD
Amoxapine—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000739	0.00151	CcSEcCtD
Amoxapine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000737	0.00151	CcSEcCtD
Amoxapine—Headache—Topotecan—peripheral nervous system neoplasm	0.000736	0.0015	CcSEcCtD
Amoxapine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000735	0.0015	CcSEcCtD
Amoxapine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000735	0.0015	CcSEcCtD
Amoxapine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000734	0.0015	CcSEcCtD
Amoxapine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000734	0.0015	CcSEcCtD
Amoxapine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000734	0.0015	CcSEcCtD
Amoxapine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000734	0.0015	CcSEcCtD
Amoxapine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000732	0.0015	CcSEcCtD
Amoxapine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000731	0.0015	CcSEcCtD
Amoxapine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00073	0.00149	CcSEcCtD
Amoxapine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00073	0.00149	CcSEcCtD
Amoxapine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000729	0.00149	CcSEcCtD
Amoxapine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000728	0.00149	CcSEcCtD
Amoxapine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000728	0.00149	CcSEcCtD
Amoxapine—Rash—Melphalan—peripheral nervous system neoplasm	0.000725	0.00148	CcSEcCtD
Amoxapine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000725	0.00148	CcSEcCtD
Amoxapine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000722	0.00148	CcSEcCtD
Amoxapine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000717	0.00147	CcSEcCtD
Amoxapine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000703	0.00144	CcSEcCtD
Amoxapine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000702	0.00143	CcSEcCtD
Amoxapine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000698	0.00143	CcSEcCtD
Amoxapine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000698	0.00143	CcSEcCtD
Amoxapine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000698	0.00143	CcSEcCtD
Amoxapine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000696	0.00142	CcSEcCtD
Amoxapine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000695	0.00142	CcSEcCtD
Amoxapine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000692	0.00142	CcSEcCtD
Amoxapine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000692	0.00142	CcSEcCtD
Amoxapine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000684	0.0014	CcSEcCtD
Amoxapine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000683	0.0014	CcSEcCtD
Amoxapine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000683	0.0014	CcSEcCtD
Amoxapine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000676	0.00138	CcSEcCtD
Amoxapine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000675	0.00138	CcSEcCtD
Amoxapine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000673	0.00138	CcSEcCtD
Amoxapine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000673	0.00138	CcSEcCtD
Amoxapine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000673	0.00138	CcSEcCtD
Amoxapine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000673	0.00138	CcSEcCtD
Amoxapine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000666	0.00136	CcSEcCtD
Amoxapine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000661	0.00215	CbGeAlD
Amoxapine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000657	0.00134	CcSEcCtD
Amoxapine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000654	0.00134	CcSEcCtD
Amoxapine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000652	0.00133	CcSEcCtD
Amoxapine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000644	0.00132	CcSEcCtD
Amoxapine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000634	0.0013	CcSEcCtD
Amoxapine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000628	0.00128	CcSEcCtD
Amoxapine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000625	0.00128	CcSEcCtD
Amoxapine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000623	0.00127	CcSEcCtD
Amoxapine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00062	0.00127	CcSEcCtD
Amoxapine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000619	0.00127	CcSEcCtD
Amoxapine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000618	0.00126	CcSEcCtD
Amoxapine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000616	0.00126	CcSEcCtD
Amoxapine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000613	0.00125	CcSEcCtD
Amoxapine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000611	0.00125	CcSEcCtD
Amoxapine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000606	0.00124	CcSEcCtD
Amoxapine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000606	0.00124	CcSEcCtD
Amoxapine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000604	0.00124	CcSEcCtD
Amoxapine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000601	0.00123	CcSEcCtD
Amoxapine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000599	0.00123	CcSEcCtD
Amoxapine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000595	0.00122	CcSEcCtD
Amoxapine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000594	0.00121	CcSEcCtD
Amoxapine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000591	0.00121	CcSEcCtD
Amoxapine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000591	0.00121	CcSEcCtD
Amoxapine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000589	0.00121	CcSEcCtD
Amoxapine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000584	0.00119	CcSEcCtD
Amoxapine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000582	0.00119	CcSEcCtD
Amoxapine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000581	0.00119	CcSEcCtD
Amoxapine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000572	0.00117	CcSEcCtD
Amoxapine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000568	0.00116	CcSEcCtD
Amoxapine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000566	0.00116	CcSEcCtD
Amoxapine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000565	0.00116	CcSEcCtD
Amoxapine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000564	0.00115	CcSEcCtD
Amoxapine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000563	0.00115	CcSEcCtD
Amoxapine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000562	0.00183	CbGeAlD
Amoxapine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000562	0.00115	CcSEcCtD
Amoxapine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.00115	CcSEcCtD
Amoxapine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000557	0.00114	CcSEcCtD
Amoxapine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000556	0.00114	CcSEcCtD
Amoxapine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000553	0.00113	CcSEcCtD
Amoxapine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000548	0.00112	CcSEcCtD
Amoxapine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.00112	CcSEcCtD
Amoxapine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.00112	CcSEcCtD
Amoxapine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000545	0.00111	CcSEcCtD
Amoxapine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000545	0.00111	CcSEcCtD
Amoxapine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000544	0.00111	CcSEcCtD
Amoxapine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000541	0.00111	CcSEcCtD
Amoxapine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000541	0.00111	CcSEcCtD
Amoxapine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00054	0.0011	CcSEcCtD
Amoxapine—Rash—Vincristine—peripheral nervous system neoplasm	0.000537	0.0011	CcSEcCtD
Amoxapine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000536	0.0011	CcSEcCtD
Amoxapine—Headache—Vincristine—peripheral nervous system neoplasm	0.000533	0.00109	CcSEcCtD
Amoxapine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000525	0.00107	CcSEcCtD
Amoxapine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000523	0.00107	CcSEcCtD
Amoxapine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000515	0.00105	CcSEcCtD
Amoxapine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000512	0.00167	CbGeAlD
Amoxapine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000507	0.00104	CcSEcCtD
Amoxapine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000505	0.00103	CcSEcCtD
Amoxapine—Olanzapine—ABCB1—peripheral nervous system neoplasm	0.000505	0.184	CrCbGaD
Amoxapine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000503	0.00103	CcSEcCtD
Amoxapine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.00102	CcSEcCtD
Amoxapine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000495	0.00101	CcSEcCtD
Amoxapine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000488	0.000997	CcSEcCtD
Amoxapine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000983	CcSEcCtD
Amoxapine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000478	0.000978	CcSEcCtD
Amoxapine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000474	0.00097	CcSEcCtD
Amoxapine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000474	0.000969	CcSEcCtD
Amoxapine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000472	0.000964	CcSEcCtD
Amoxapine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000469	0.000959	CcSEcCtD
Amoxapine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000467	0.000954	CcSEcCtD
Amoxapine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000465	0.00095	CcSEcCtD
Amoxapine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000464	0.000948	CcSEcCtD
Amoxapine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00046	0.00094	CcSEcCtD
Amoxapine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000456	0.000932	CcSEcCtD
Amoxapine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000447	0.000914	CcSEcCtD
Amoxapine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000446	0.000912	CcSEcCtD
Amoxapine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000909	CcSEcCtD
Amoxapine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000438	0.000896	CcSEcCtD
Amoxapine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000435	0.000889	CcSEcCtD
Amoxapine—Rash—Etoposide—peripheral nervous system neoplasm	0.000435	0.000889	CcSEcCtD
Amoxapine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000434	0.000888	CcSEcCtD
Amoxapine—Headache—Etoposide—peripheral nervous system neoplasm	0.000432	0.000883	CcSEcCtD
Amoxapine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000883	CcSEcCtD
Amoxapine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.000879	CcSEcCtD
Amoxapine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.000877	CcSEcCtD
Amoxapine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000425	0.00087	CcSEcCtD
Amoxapine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000425	0.000868	CcSEcCtD
Amoxapine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000866	CcSEcCtD
Amoxapine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000418	0.000855	CcSEcCtD
Amoxapine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000851	CcSEcCtD
Amoxapine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000844	CcSEcCtD
Amoxapine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00041	0.000839	CcSEcCtD
Amoxapine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000409	0.000837	CcSEcCtD
Amoxapine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000409	0.000836	CcSEcCtD
Amoxapine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000823	CcSEcCtD
Amoxapine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000806	CcSEcCtD
Amoxapine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000803	CcSEcCtD
Amoxapine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000802	CcSEcCtD
Amoxapine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000797	CcSEcCtD
Amoxapine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000791	CcSEcCtD
Amoxapine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000386	0.00079	CcSEcCtD
Amoxapine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000787	CcSEcCtD
Amoxapine—Shock—Epirubicin—peripheral nervous system neoplasm	0.00038	0.000777	CcSEcCtD
Amoxapine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000776	CcSEcCtD
Amoxapine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000773	CcSEcCtD
Amoxapine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000773	CcSEcCtD
Amoxapine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000771	CcSEcCtD
Amoxapine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000753	CcSEcCtD
Amoxapine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000746	CcSEcCtD
Amoxapine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000738	CcSEcCtD
Amoxapine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000737	CcSEcCtD
Amoxapine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000731	CcSEcCtD
Amoxapine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000719	CcSEcCtD
Amoxapine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000716	CcSEcCtD
Amoxapine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000714	CcSEcCtD
Amoxapine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000713	CcSEcCtD
Amoxapine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000709	CcSEcCtD
Amoxapine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000702	CcSEcCtD
Amoxapine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000697	CcSEcCtD
Amoxapine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000695	CcSEcCtD
Amoxapine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000687	CcSEcCtD
Amoxapine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000683	CcSEcCtD
Amoxapine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000681	CcSEcCtD
Amoxapine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000676	CcSEcCtD
Amoxapine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000661	CcSEcCtD
Amoxapine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000656	CcSEcCtD
Amoxapine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000651	CcSEcCtD
Amoxapine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.00065	CcSEcCtD
Amoxapine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000646	CcSEcCtD
Amoxapine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000643	CcSEcCtD
Amoxapine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000635	CcSEcCtD
Amoxapine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.00063	CcSEcCtD
Amoxapine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000628	CcSEcCtD
Amoxapine—Quetiapine—ABCB1—peripheral nervous system neoplasm	0.000306	0.111	CrCbGaD
Amoxapine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000625	CcSEcCtD
Amoxapine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000624	CcSEcCtD
Amoxapine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000624	CcSEcCtD
Amoxapine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000602	CcSEcCtD
Amoxapine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000598	CcSEcCtD
Amoxapine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000581	CcSEcCtD
Amoxapine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000578	CcSEcCtD
Amoxapine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000578	CcSEcCtD
Amoxapine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000567	CcSEcCtD
Amoxapine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000559	CcSEcCtD
Amoxapine—Diazepam—ABCB1—peripheral nervous system neoplasm	0.000267	0.097	CrCbGaD
Amoxapine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000264	0.00054	CcSEcCtD
Amoxapine—Clozapine—ABCB1—peripheral nervous system neoplasm	0.000264	0.0958	CrCbGaD
Amoxapine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000524	CcSEcCtD
Amoxapine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000522	CcSEcCtD
Amoxapine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000517	CcSEcCtD
Amoxapine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000502	CcSEcCtD
Amoxapine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.0005	CcSEcCtD
Amoxapine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000498	CcSEcCtD
Amoxapine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000498	CcSEcCtD
Amoxapine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000495	CcSEcCtD
Amoxapine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000483	CcSEcCtD
Amoxapine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000469	CcSEcCtD
Amoxapine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000465	CcSEcCtD
Amoxapine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000461	CcSEcCtD
Amoxapine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.00046	CcSEcCtD
Amoxapine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000458	CcSEcCtD
Amoxapine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000434	CcSEcCtD
Amoxapine—DRD3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.17e-05	0.000257	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.16e-05	0.000256	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.1e-05	0.000253	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	5.06e-05	0.000252	CbGpPWpGaD
Amoxapine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	5.02e-05	0.000249	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.86e-05	0.000242	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.86e-05	0.000241	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.85e-05	0.000241	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.84e-05	0.00024	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.83e-05	0.00024	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.81e-05	0.000239	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.78e-05	0.000237	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.77e-05	0.000237	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	4.76e-05	0.000236	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.75e-05	0.000236	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.74e-05	0.000236	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.73e-05	0.000235	CbGpPWpGaD
Amoxapine—HRH4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.73e-05	0.000235	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.7e-05	0.000234	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.68e-05	0.000233	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.68e-05	0.000232	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.51e-05	0.000224	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.48e-05	0.000223	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.34e-05	0.000216	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.29e-05	0.000213	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.27e-05	0.000212	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.2e-05	0.000209	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.19e-05	0.000208	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.18e-05	0.000208	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.15e-05	0.000206	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.13e-05	0.000205	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.11e-05	0.000204	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.11e-05	0.000204	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.08e-05	0.000203	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.08e-05	0.000202	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.06e-05	0.000202	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	4.01e-05	0.000199	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4e-05	0.000199	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.96e-05	0.000197	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.95e-05	0.000196	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.95e-05	0.000196	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.92e-05	0.000195	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	3.9e-05	0.000194	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.89e-05	0.000193	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	3.89e-05	0.000193	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.88e-05	0.000193	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.88e-05	0.000193	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.88e-05	0.000193	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.87e-05	0.000192	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.84e-05	0.000191	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.82e-05	0.00019	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	3.81e-05	0.000189	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.81e-05	0.000189	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.78e-05	0.000188	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.77e-05	0.000187	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.72e-05	0.000185	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.71e-05	0.000184	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.66e-05	0.000182	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.63e-05	0.00018	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.61e-05	0.000179	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.57e-05	0.000177	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.56e-05	0.000177	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.55e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.54e-05	0.000176	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.54e-05	0.000176	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.5e-05	0.000174	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.4e-05	0.000169	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.36e-05	0.000167	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.34e-05	0.000166	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	3.3e-05	0.000164	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.3e-05	0.000164	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.25e-05	0.000161	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.15e-05	0.000156	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	3.1e-05	0.000154	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.07e-05	0.000152	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.06e-05	0.000152	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	3.06e-05	0.000152	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—TP53—peripheral nervous system neoplasm	3e-05	0.000149	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.98e-05	0.000148	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.93e-05	0.000146	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	2.93e-05	0.000146	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.92e-05	0.000145	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.91e-05	0.000145	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.89e-05	0.000144	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.89e-05	0.000143	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.87e-05	0.000143	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.87e-05	0.000143	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.86e-05	0.000142	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.81e-05	0.00014	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.81e-05	0.00014	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.81e-05	0.000139	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.8e-05	0.000139	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.78e-05	0.000138	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.78e-05	0.000138	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.76e-05	0.000137	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.73e-05	0.000136	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.71e-05	0.000134	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.69e-05	0.000133	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.66e-05	0.000132	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.64e-05	0.000131	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.64e-05	0.000131	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.61e-05	0.000129	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	2.59e-05	0.000129	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.57e-05	0.000128	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.57e-05	0.000127	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.55e-05	0.000127	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.55e-05	0.000127	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.54e-05	0.000126	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.54e-05	0.000126	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	2.53e-05	0.000126	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.53e-05	0.000126	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.52e-05	0.000125	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.52e-05	0.000125	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.51e-05	0.000125	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.49e-05	0.000124	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.49e-05	0.000123	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.48e-05	0.000123	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.48e-05	0.000123	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.48e-05	0.000123	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.47e-05	0.000123	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.47e-05	0.000123	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.46e-05	0.000122	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.44e-05	0.000121	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.43e-05	0.000121	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.42e-05	0.00012	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.4e-05	0.000119	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.39e-05	0.000119	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.37e-05	0.000117	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.33e-05	0.000116	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.33e-05	0.000116	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.33e-05	0.000116	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.3e-05	0.000114	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.27e-05	0.000113	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.27e-05	0.000113	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.26e-05	0.000112	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.26e-05	0.000112	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.23e-05	0.000111	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.2e-05	0.000109	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.17e-05	0.000108	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.17e-05	0.000108	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.17e-05	0.000108	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.14e-05	0.000106	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.13e-05	0.000106	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.13e-05	0.000106	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.11e-05	0.000105	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.08e-05	0.000103	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.08e-05	0.000103	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.07e-05	0.000103	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.06e-05	0.000102	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.05e-05	0.000102	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.01e-05	9.98e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.99e-05	9.9e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.98e-05	9.86e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.98e-05	9.85e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.96e-05	9.75e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.96e-05	9.72e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.95e-05	9.69e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.92e-05	9.54e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.89e-05	9.38e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.88e-05	9.34e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.88e-05	9.33e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.87e-05	9.3e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.85e-05	9.18e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.85e-05	9.17e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.84e-05	9.16e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.84e-05	9.13e-05	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.83e-05	9.07e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.81e-05	8.99e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.81e-05	8.99e-05	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.8e-05	8.93e-05	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.79e-05	8.91e-05	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.79e-05	8.88e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.79e-05	8.87e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.78e-05	8.87e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.78e-05	8.86e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.78e-05	8.85e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.78e-05	8.83e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.77e-05	8.8e-05	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.76e-05	8.74e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.74e-05	8.66e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.73e-05	8.62e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.73e-05	8.58e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.72e-05	8.54e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.71e-05	8.48e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.71e-05	8.48e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.71e-05	8.47e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.68e-05	8.35e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.66e-05	8.24e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.66e-05	8.24e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.64e-05	8.12e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.63e-05	8.11e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.63e-05	8.11e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.63e-05	8.1e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.63e-05	8.09e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.62e-05	8.06e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.62e-05	8.05e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.61e-05	7.99e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.6e-05	7.95e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.6e-05	7.94e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.56e-05	7.74e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.54e-05	7.63e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.52e-05	7.54e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.52e-05	7.53e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.51e-05	7.49e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.51e-05	7.48e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.49e-05	7.41e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.49e-05	7.4e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.48e-05	7.38e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.48e-05	7.37e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.47e-05	7.3e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.47e-05	7.28e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.46e-05	7.26e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.45e-05	7.2e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.44e-05	7.16e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.41e-05	7.02e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.39e-05	6.91e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.39e-05	6.89e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.38e-05	6.87e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.38e-05	6.84e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.36e-05	6.76e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.36e-05	6.75e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.32e-05	6.57e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.31e-05	6.53e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.3e-05	6.45e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.28e-05	6.36e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.26e-05	6.28e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.26e-05	6.28e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.26e-05	6.25e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.16e-05	5.76e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.14e-05	5.67e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.14e-05	5.66e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.14e-05	5.64e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.12e-05	5.55e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.12e-05	5.54e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.11e-05	5.52e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.11e-05	5.51e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.09e-05	5.42e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.09e-05	5.41e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.09e-05	5.4e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.07e-05	5.31e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	1.05e-05	5.21e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.04e-05	5.16e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.93e-06	4.93e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.8e-06	4.87e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.64e-06	4.79e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.62e-06	4.78e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.59e-06	4.76e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.44e-06	4.69e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.77e-06	4.36e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	6.84e-06	3.4e-05	CbGpPWpGaD
